A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer.
Lin ChenYan LinZijun ZhangRuisheng YangXiaosheng BaiZhongbing LiuZhongling LuoMeiling ZhouZhirong ZhongPublished in: Journal of nanobiotechnology (2021)
Therefore, BBA/FA-PEG-CM-β-CD may have clinical potential in colon cancer therapy.